QA: Arbutus Biopharma Corp in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001447028_2023_Arbutus_Biopharma_Corp.pdf

Logs

Graph

Absolute values for 0001447028, Arbutus Biopharma Corp

  xvar xval
0 AssetsCurrent 151,139,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,070,000
3 remainder_Assets 39,210,000
4 LiabilitiesCurrent 32,857,000
5 LiabilitiesNoncurrent 1,815,000
6 remainder_Liabilities 23,895,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,834,000
9 ResearchAndDevelopmentExpense 84,408,000
10 remainder_Expenses 6,677,000
11 remainder_Revenues 39,019,000
12 remainder_NetIncome 444,000
13 remainder_ComprehensiveNetIncome -2,153,000
  yvar yval
0 Assets 195,419,000
1 Liabilities 58,567,000
2 Expenses 108,919,000
3 Revenues 39,019,000
4 StockholdersEquity 136,852,000
5 NetIncome -69,456,000
6 ComprehensiveNetIncome -70,532,500
7 BaseVar 202,260,500
8 EconomicCapitalRatio 1.30

Edgar->Model Mapping

Feature Distribution

Change over Time